Recent Posts
- OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
- OKYO Pharma Announces Purchase of Shares by Chairman
- OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
- OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
- OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
Recent Comments
No comments to show.